Pharmaceutical Executive
CMS Signals Looming Sunshine Act Audits: How to Prepare
March 1, 2024
New guidance suggests that CMS may be ramping up Sunshine Act auditing activities, potentially resulting in monetary liability for noncompliant reporting entities.
After more than a decade of relative inactivity, the Centers for Medicare & Medicaid Services(CMS) has signaled that it may soon commence audits of reporting entities under the Sunshine Act.
Published by Pharmaceutical Executive on March 1, 2024, available at https://www.pharmexec.com/view/cms-signals-looming-sunshine-act-audits-how-to-prepare.
Contacts
Capabilities
Suggested News & Insights
Medical Products Market Access: Favorable Advisory Opinion Reaffirms Discounting FlexibilitiesJanuary 21, 2026FY 2025 FCA Settlements and Judgments Statistics Show Highest Recoveries EverJanuary 20, 2026Korea Night @ JPM 2026Wednesday, January 14, 2026Recharge & Recaffeinate with Sidley @ JPMMonday, January 12, 2026 – Tuesday, January 13, 2026Biotech Dealmaking – Regulatory Considerations for the Next Wave of Development-Stage Transactions – Program and Lunch @ JPM 2026Monday, January 12, 2026Sidley Represents Smith+Nephew in Integrity Orthopaedics Acquisition Valued Up to US$450 MillionJanuary 12, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory

